Evidence map›Paper›PMID 33922765›Full record

ArticlePathogens (Basel, Switzerland)2021

Further Characterization of Glycoform-Selective Prions of Variably Protease-Sensitive Prionopathy.

Weiguanliu Zhang, Xiangzhu Xiao, Mingxuan Ding, Jue Yuan, Aaron Foutz, Mohammed Moudjou, Tetsuyuki Kitamoto, Jan P M Langeveld, Li Cui, Wen-Quan Zou

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Weiguanliu ZhangDepartment of Neurology, The First Hospital of Jilin University, Changchun 130000, China.
Xiangzhu XiaoDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Mingxuan DingDepartment of Neurology, The First Hospital of Jilin University, Changchun 130000, China.
Jue YuanDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Aaron FoutzDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Mohammed MoudjouMolecular Virology and Immunology Unit (VIM), Université Paris Saclay, INRAE, UVSQ, VIM, 78350 Jouy-en-Josas, France.ORCID 0000-0001-6887-0190
Tetsuyuki KitamotoDepartment of Neurological Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
Jan P M LangeveldDepartment of Infection Biology, Wageningen Bioveterinary Research, 8221RA 39 Lelystad, The Netherlands.
Li CuiDepartment of Neurology, The First Hospital of Jilin University, Changchun 130000, China.
Wen-Quan ZouDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
University School · USJilin University · CNTohoku University · JPUniversité de Versailles Saint-Quentin-en-Yvelines · FRWageningen University & Research · NL

Funding

Role of skin prions in disease transmission and diagnostic testing of human prion diseaseR01NS109532 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI KONG, QINGZHONG · 2018 to 2022
$2.9M
NINDS NIH HHS NS109532NINDS NIH HHS R01 NS109532
6 · The paper itself

Abstract

Prion is an infectious protein (PrP

Indexed as

Creutzfeldt-Jakob disease (CJD)Gerstmann-Sträussler-Scheinker (GSS)glycoform-selective prion formationprions diseasereal-time quaking-induced conversion (RT-QuIC) assayvariably protease-sensitive prionopathy (VPSPr)

Identifiers

PMID33922765
PMCPMC8146342
OpenAlexW3157963821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.